SitesBLAST
Comparing WP_028988986.1 NCBI__GCF_000423825.1:WP_028988986.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
3gd4A Crystal structure of the reduced, NAD-bound form of murine apoptosis inducing factor (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 6:426/445 of 3gd4A
- binding flavin-adenine dinucleotide: I9 (= I9), G10 (= G10), G11 (≠ A11), G12 (= G12), T13 (≠ L13), A14 (= A14), V34 (≠ I34), S35 (≠ G35), E36 (≠ G36), R44 (= R44), P45 (= P45), S48 (= S48), K104 (≠ A81), V105 (≠ A82), T132 (≠ M109), G133 (= G110), R157 (≠ Q128), G309 (= G275), D310 (= D276), E325 (= E292), H326 (= H293), H327 (≠ W294), A330 (= A297), W355 (≠ F322)
- binding nicotinamide-adenine-dinucleotide: L139 (= L116), G180 (= G151), G181 (≠ S152), F182 (= F153), L183 (≠ I154), E186 (= E157), P207 (= P175), E208 (≠ G176), K214 (≠ Q182), A269 (≠ G237), V270 (= V238), G271 (= G239), E325 (= E292), H326 (= H293), W355 (≠ F322), S356 (= S323)
8qnsA Crystal structure of murine aif bound to n-terminal domain of chchd4 (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 9:423/449 of 8qnsA
- binding flavin-adenine dinucleotide: G13 (= G10), G15 (= G12), T16 (≠ L13), A17 (= A14), E39 (≠ G36), R47 (= R44), P48 (= P45), S51 (= S48), K52 (= K49), K107 (≠ A81), V108 (≠ A82), T135 (≠ M109), G136 (= G110), F159 (≠ L127), R160 (≠ Q128), G312 (= G275), D313 (= D276), E328 (= E292), H329 (= H293), H330 (≠ W294), W358 (≠ F322)
- binding nicotinamide-adenine-dinucleotide: L142 (= L116), G183 (= G151), G184 (≠ S152), F185 (= F153), L186 (≠ I154), E189 (= E157), P210 (= P175), E211 (≠ G176), K217 (≠ Q182), A272 (≠ G237), V273 (= V238), G274 (= G239), E328 (= E292), H329 (= H293), W358 (≠ F322), S359 (= S323)
- binding : P220 (= P185), Y222 (≠ P187), S375 (= S338), S376 (≠ R339), L377 (= L340), P378 (≠ E341), T379 (= T342), V380 (≠ F343), G381 (vs. gap), V382 (vs. gap), F383 (vs. gap), A384 (vs. gap), K385 (≠ V344), T387 (≠ M346), E389 (≠ A348), Y391 (= Y350)
Sites not aligning to the query:
8d3jA Crystal structure of human apoptosis-inducing factor (aif) complexed with 6-fluoro-2-methylquinolin-4-amine (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 8:413/436 of 8d3jA
- binding flavin-adenine dinucleotide: G12 (= G10), A16 (= A14), E38 (≠ G36), D39 (≠ E37), R46 (= R44), P47 (= P45), K51 (= K49), K103 (≠ A81), V104 (≠ A82), T131 (≠ M109), F155 (≠ L127), R156 (≠ Q128), G308 (= G275), D309 (= D276), E324 (= E292), H325 (= H293), H326 (≠ W294), W354 (≠ F322)
- binding 6-fluoro-2-methylquinolin-4-amine: F181 (= F153), L182 (≠ I154), E185 (= E157), H325 (= H293), F353 (= F321), W354 (≠ F322), S355 (= S323)
8vgyA Crystal structure of human apoptosis-inducing factor (aif) bound to the fused n-terminal domain of chchd4
35% identity, 95% coverage: 6:382/398 of query aligns to 8:420/473 of 8vgyA
- binding flavin-adenine dinucleotide: G12 (= G10), G13 (≠ A11), A16 (= A14), E38 (≠ G36), R46 (= R44), P47 (= P45), K51 (= K49), K106 (≠ A81), V107 (≠ A82), T134 (≠ M109), F158 (≠ L127), R159 (≠ Q128), F184 (= F153), G311 (= G275), D312 (= D276), H328 (= H293), H329 (≠ W294), W357 (≠ F322)
8d3hB Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with 7-chloroquinolin-4-amine (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 8:412/434 of 8d3hB
- binding flavin-adenine dinucleotide: G12 (= G10), G14 (= G12), T15 (≠ L13), A16 (= A14), V36 (≠ I34), E38 (≠ G36), D39 (≠ E37), R46 (= R44), P47 (= P45), K51 (= K49), K103 (≠ A81), V104 (≠ A82), T131 (≠ M109), F155 (≠ L127), R156 (≠ Q128), G308 (= G275), D309 (= D276), E324 (= E292), H325 (= H293), H326 (≠ W294), A329 (= A297), W354 (≠ F322)
- binding 7-chloroquinolin-4-amine: L182 (≠ I154), E185 (= E157), F353 (= F321), W354 (≠ F322)
8d3gB Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with 6-chloroquinolin-4-amine (see paper)
35% identity, 95% coverage: 6:382/398 of query aligns to 6:405/432 of 8d3gB
- binding flavin-adenine dinucleotide: G10 (= G10), G11 (≠ A11), G12 (= G12), A14 (= A14), E36 (≠ G36), R44 (= R44), P45 (= P45), K49 (= K49), K101 (≠ A81), V102 (≠ A82), T129 (≠ M109), F153 (≠ L127), R154 (≠ Q128), G306 (= G275), D307 (= D276), H323 (= H293), H324 (≠ W294), A327 (= A297)
- binding 6-chloroquinolin-4-amine: F179 (= F153), L180 (≠ I154), E183 (= E157), H323 (= H293), F351 (= F321)
8d3kA Crystal structure of human apoptosis-inducing factor (aif) complexed with 8-fluoro-2-methylquinolin-4-amine (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 8:414/437 of 8d3kA
- binding flavin-adenine dinucleotide: G12 (= G10), G13 (≠ A11), A16 (= A14), E38 (≠ G36), D39 (≠ E37), R46 (= R44), P47 (= P45), K51 (= K49), K104 (≠ A81), V105 (≠ A82), T132 (≠ M109), F156 (≠ L127), R157 (≠ Q128), G309 (= G275), D310 (= D276), E325 (= E292), H326 (= H293), H327 (≠ W294), A330 (= A297), W355 (≠ F322)
- binding 8-fluoro-2-methylquinolin-4-amine: F182 (= F153), L183 (≠ I154), E186 (= E157), H326 (= H293), F354 (= F321), W355 (≠ F322), S356 (= S323)
8d3iA Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with quinolin-4-amine (see paper)
36% identity, 95% coverage: 6:382/398 of query aligns to 8:416/439 of 8d3iA
- binding quinolin-4-amine: F184 (= F153), L185 (≠ I154), E188 (= E157), W357 (≠ F322)
- binding flavin-adenine dinucleotide: G12 (= G10), A16 (= A14), E38 (≠ G36), D39 (≠ E37), R46 (= R44), P47 (= P45), K51 (= K49), K106 (≠ A81), V107 (≠ A82), T134 (≠ M109), F158 (≠ L127), G311 (= G275), D312 (= D276), E327 (= E292), H328 (= H293), H329 (≠ W294), W357 (≠ F322)
3gd3A Crystal structure of a naturally folded murine apoptosis inducing factor (see paper)
34% identity, 95% coverage: 6:382/398 of query aligns to 6:444/463 of 3gd3A
- binding flavin-adenine dinucleotide: G10 (= G10), G12 (= G12), T13 (≠ L13), E36 (≠ G36), R44 (= R44), P45 (= P45), K49 (= K49), K104 (≠ A81), V105 (≠ A82), T132 (≠ M109), G133 (= G110), R157 (≠ Q128), L183 (≠ I154), D310 (= D276), E325 (= E292), H326 (= H293), H327 (≠ W294), F354 (= F321), W355 (≠ F322)
- binding : P375 (vs. gap), T376 (vs. gap), G378 (vs. gap), V379 (vs. gap), F380 (vs. gap)
8d3oA Crystal structure of human apoptosis-inducing factor (aif) complexed with 8-methoxyquinolin-4-amine (see paper)
35% identity, 95% coverage: 6:382/398 of query aligns to 8:413/436 of 8d3oA
- binding flavin-adenine dinucleotide: G12 (= G10), A16 (= A14), E38 (≠ G36), D39 (≠ E37), R46 (= R44), P47 (= P45), K51 (= K49), K104 (≠ A81), V105 (≠ A82), T132 (≠ M109), G133 (= G110), F156 (≠ L127), R157 (≠ Q128), G309 (= G275), D310 (= D276), E325 (= E292), H326 (= H293), H327 (≠ W294), A330 (= A297)
- binding 8-methoxyquinolin-4-amine: F182 (= F153), L183 (≠ I154), E186 (= E157), E325 (= E292), H326 (= H293), F354 (= F321)
8d3gA Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with 6-chloroquinolin-4-amine (see paper)
35% identity, 95% coverage: 6:382/398 of query aligns to 7:406/431 of 8d3gA
- binding flavin-adenine dinucleotide: G11 (= G10), T14 (≠ L13), A15 (= A14), E37 (≠ G36), D38 (≠ E37), R45 (= R44), P46 (= P45), K50 (= K49), K102 (≠ A81), V103 (≠ A82), T130 (≠ M109), G131 (= G110), F154 (≠ L127), R155 (≠ Q128), G307 (= G275), D308 (= D276), H324 (= H293), H325 (≠ W294), A328 (= A297)
- binding 6-chloroquinolin-4-amine: F180 (= F153), L181 (≠ I154), E184 (= E157), H324 (= H293), F352 (= F321)
8d3hA Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with 7-chloroquinolin-4-amine (see paper)
35% identity, 95% coverage: 6:382/398 of query aligns to 6:413/432 of 8d3hA
- binding flavin-adenine dinucleotide: G10 (= G10), G11 (≠ A11), T13 (≠ L13), A14 (= A14), E36 (≠ G36), D37 (≠ E37), R44 (= R44), P45 (= P45), S48 (= S48), K49 (= K49), K104 (≠ A81), V105 (≠ A82), T132 (≠ M109), G133 (= G110), F156 (≠ L127), R157 (≠ Q128), G309 (= G275), D310 (= D276), H326 (= H293), H327 (≠ W294), A330 (= A297), W355 (≠ F322)
- binding 7-chloroquinolin-4-amine: F182 (= F153), L183 (≠ I154), E186 (= E157), W355 (≠ F322)
8d3eA Crystal structure of human apoptosis-inducing factor (aif) w196a mutant complexed with 6-fluoroquinolin-4-amine (see paper)
35% identity, 95% coverage: 6:382/398 of query aligns to 7:414/433 of 8d3eA
- binding flavin-adenine dinucleotide: G11 (= G10), G12 (≠ A11), A15 (= A14), E37 (≠ G36), D38 (≠ E37), R45 (= R44), P46 (= P45), K50 (= K49), K105 (≠ A81), V106 (≠ A82), T133 (≠ M109), F157 (≠ L127), R158 (≠ Q128), G310 (= G275), D311 (= D276), E326 (= E292), H327 (= H293), H328 (≠ W294), A331 (= A297), W356 (≠ F322)
- binding 6-fluoroquinolin-4-amine: F183 (= F153), L184 (≠ I154), E187 (= E157), E326 (= E292), H327 (= H293), F355 (= F321)
Q9Z0X1 Apoptosis-inducing factor 1, mitochondrial; Programmed cell death protein 8; EC 1.6.99.- from Mus musculus (Mouse) (see 4 papers)
33% identity, 95% coverage: 6:382/398 of query aligns to 133:591/612 of Q9Z0X1
- GGGTA 137:141 (≠ GAGLA 10:14) binding FAD
- ED 163:164 (≠ GE 36:37) binding FAD
- R171 (= R44) binding FAD
- K176 (= K49) binding FAD; mutation to A: Increases catalytic efficiency.
- W195 (vs. gap) mutation to A: Increases redox potential, reacts faster to NADH and forms two-fold longer-lived CTC.
- V232 (≠ A82) binding FAD
- K254 (= K104) mutation to A: Abolished DNA-binding without affecting binding to poly-ADP-ribose chains; when associated with A-264.
- R264 (= R114) mutation to A: Abolished DNA-binding without affecting binding to poly-ADP-ribose chains; when associated with A-254.
- R284 (≠ Q128) binding FAD
- GGFL 307:310 (≠ GSFI 151:154) binding NAD(+)
- E313 (= E157) mutation to A: Increases catalytic efficiency 30-fold. Increases affinity for NADH 20-fold.
- E335 (≠ G176) binding NAD(+)
- K341 (≠ Q182) binding NAD(+)
- G398 (= G239) binding NAD(+)
- D437 (= D276) binding FAD
- EH 452:453 (= EH 292:293) binding NAD(+)
- HH 453:454 (≠ HW 293:294) binding FAD
- W482 (≠ F322) binding FAD; binding NAD(+)
Sites not aligning to the query:
- 55:101 modified: propeptide, Removed in mature form
- 588:592 RKIIK→AAIIA: Abolished binding to poly-ADP-ribose chains, preventing induction of parthanatos.
1gv4A Murine apoptosis-inducing factor (aif) (see paper)
33% identity, 95% coverage: 6:382/398 of query aligns to 13:471/490 of 1gv4A
- active site: L198 (= L162), E437 (≠ A348), G442 (= G353), V443 (≠ T354)
- binding flavin-adenine dinucleotide: G17 (= G10), G19 (= G12), T20 (≠ L13), A21 (= A14), E43 (≠ G36), D44 (≠ E37), R51 (= R44), P52 (= P45), K56 (= K49), K111 (≠ A81), V112 (≠ A82), T139 (≠ M109), G140 (= G110), F163 (≠ L127), R164 (≠ Q128), G316 (= G275), D317 (= D276), E332 (= E292), H333 (= H293), H334 (≠ W294), F361 (= F321), W362 (≠ F322)
O95831 Apoptosis-inducing factor 1, mitochondrial; Programmed cell death protein 8; EC 1.6.99.- from Homo sapiens (Human) (see 16 papers)
32% identity, 95% coverage: 6:382/398 of query aligns to 134:592/613 of O95831
- GGGTA 138:142 (≠ GAGLA 10:14) binding FAD
- ED 164:165 (≠ GE 36:37) binding FAD
- R172 (= R44) binding FAD
- K177 (= K49) binding FAD
- W196 (vs. gap) binding NAD(+); mutation to A: Increases protein dimerization at lower NADH levels.
- R201 (≠ E59) natural variant: Missing (in COXPD6; higher DNA binding affinity, partially impaired flavin binding and association with increased parthanatos-linked cell death; dbSNP:rs387906500)
- V233 (≠ A82) binding FAD
- Q235 (≠ E84) to H: in SEMDHL; severe decrease of protein expression; dbSNP:rs377527583
- V243 (= V92) to L: in COXPD6; reduced protein amount in muscle compared to controls; no effect on reduction with NADH; strongly decreased NADH oxidase activity; no effect on dimerization; no effect on DNA-binding; dbSNP:rs1603225138
- K255 (= K104) modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
- G262 (= G111) to S: found in patient with mitochondrial encephalomyopathy with moderate clinical severity and slow progressive course despite early onset as well as and cerebellar involvement; likely pathogenic; decreased protein level; strongly decreased redox potential; strongly decreased NADH oxidase activity; no effect on DNA-binding; dbSNP:rs1603224817
- R285 (≠ Q128) binding FAD
- G308 (= G151) to E: in COXPD6; with prenatal ventriculomegaly and severe postnatal encephalomyopathy; no effect on redox potential; slowered reduction with NADH; strongly decreased NADH oxidase activity; strongly decreased NADH oxidase activity; no effect on DNA-binding; decreased interaction with CHCHDE; dbSNP:rs1603224226
- GGFL 308:311 (≠ GSFI 151:154) binding NAD(+)
- E336 (≠ G176) binding NAD(+)
- G338 (= G178) to E: in COXPD6; with early-onset severe motor neuron involvement; decreased protein levels; decreased oxidoreductase activity on cytochrome C; slowered reduction with NADH; strongly decreased NADH oxidase activity; strongly decreased NADH oxidase activity; no effect on DNA-binding; dbSNP:rs1603223152
- L344 (= L184) to F: in DFNX5; uncertain significance; dbSNP:rs184474885
- G360 (= G200) to R: in DFNX5; uncertain significance; dbSNP:rs724160026
- G399 (= G239) binding NAD(+)
- 413:430 (vs. 253:268, 37% identical) mutation to AIDSDFGGFAVNAELQAA: Disrupts dimerization. Lower efficiency in stabilizing charge-transfer complexes upon coenzyme reduction.
- R430 (≠ H268) to C: in DFNX5; uncertain significance; dbSNP:rs1223488720
- D438 (= D276) binding FAD
- YDI 443:445 (≠ PDP 281:283) mutation to ADA: Disrupts dimerization. Disrupts dimerization; when associated with A-477.
- EH 453:454 (= EH 292:293) binding NAD(+)
- H454 (= H293) mutation to A: Allows dimerization in absence of NADH.
- HH 454:455 (≠ HW 293:294) binding FAD
- A472 (= A311) to V: in DFNX5; uncertain significance; dbSNP:rs2124648387
- P475 (= P314) to L: in DFNX5; uncertain significance; dbSNP:rs724160022
- W477 (≠ T316) mutation to A: Disrupts dimerization; when associated with A-443--445-A.
- S480 (= S319) mutation to A: Allows dimerization in absence of NADH.
- W483 (≠ F322) binding FAD; binding NAD(+)
- D485 (= D324) mutation to A: Increases protein dimerization at lower NADH levels.
- E493 (= E331) binding NAD(+); to V: in CMTX4; increases affinity for NADH and electron transfer activity; increases affinity for DNA, resulting in increased apoptosis; no effect on interaction with CHCHD4; dbSNP:rs281864468
- V498 (≠ L336) to M: in DFNX5; uncertain significance; dbSNP:rs724160023
- R529 (vs. gap) mutation to A: Increases protein dimerization at lower NADH levels.
- E531 (vs. gap) mutation to A: Increases protein dimerization at lower NADH levels.
- E533 (vs. gap) mutation to A: Increases protein dimerization at lower NADH levels.
- E535 (vs. gap) mutation to A: Increases protein dimerization at lower NADH levels.
- N583 (≠ D373) binding NAD(+)
- I591 (≠ L381) to M: in DFNX5; uncertain significance
Sites not aligning to the query:
- 1:54 modified: transit peptide, Mitochondrion
- 55:101 modified: propeptide, Removed in mature form
P16640 Putidaredoxin reductase CamA; Pdr; Putidaredoxin--NAD(+) reductase; EC 1.18.1.5 from Pseudomonas putida (Arthrobacter siderocapsulatus) (see 2 papers)
31% identity, 98% coverage: 2:393/398 of query aligns to 3:401/422 of P16640
- A15 (= A14) binding FAD
- D37 (≠ G36) binding FAD
- K50 (= K49) binding FAD
- V83 (≠ A82) binding FAD
- R134 (≠ Q128) binding FAD
- D284 (= D276) binding FAD
- V302 (≠ W294) binding FAD
1q1wA Crystal structure of putidaredoxin reductase from pseudomonas putida (see paper)
31% identity, 98% coverage: 2:393/398 of query aligns to 2:400/422 of 1q1wA
- active site: L13 (= L13), L44 (≠ R44), P45 (= P45), L305 (≠ V298)
- binding flavin-adenine dinucleotide: G10 (= G10), G12 (= G12), L13 (= L13), A14 (= A14), G35 (= G35), D36 (≠ G36), L44 (≠ R44), P45 (= P45), K49 (= K49), V82 (≠ A82), A108 (= A108), T109 (≠ M109), G110 (= G110), R133 (≠ Q128), I159 (= I154), D283 (= D276), S300 (≠ H293), V301 (≠ W294), W329 (≠ F322)
4h4wA Crystal structure of ferredoxin reductase, bpha4 e175c/t176r/q177g mutant (reduced form)
33% identity, 95% coverage: 7:383/398 of query aligns to 6:377/399 of 4h4wA
- active site: L12 (= L13), R43 (= R44), P44 (= P45), Q290 (≠ V298)
- binding flavin-adenine dinucleotide: G11 (= G12), A13 (= A14), D35 (≠ G36), R43 (= R44), P44 (= P45), A77 (= A82), T104 (≠ M109), G105 (= G110), R125 (≠ Q128), I151 (= I154), E154 (= E157), G267 (= G275), D268 (= D276), T285 (≠ H293), W286 (= W294), A289 (= A297), W315 (≠ F322)
- binding nadp nicotinamide-adenine-dinucleotide phosphate: G148 (= G151), I151 (= I154), R171 (≠ P175), S177 (≠ A181), R178 (≠ Q182), G229 (= G237), I230 (≠ V238), G231 (= G239)
3lxdA Crystal structure of ferredoxin reductase arr from novosphingobium aromaticivorans (see paper)
33% identity, 98% coverage: 5:393/398 of query aligns to 5:397/409 of 3lxdA
- active site: H13 (≠ L13), R44 (= R44), P45 (= P45), N302 (≠ V298)
- binding flavin-adenine dinucleotide: V9 (≠ I9), G10 (= G10), G12 (= G12), H13 (≠ L13), G14 (≠ A14), R36 (≠ G36), E37 (= E37), R44 (= R44), P45 (= P45), S48 (= S48), K49 (= K49), E81 (≠ A81), V82 (≠ A82), T109 (≠ M109), I157 (= I154), G278 (= G275), D279 (= D276), S297 (≠ H293), V298 (≠ W294), F325 (= F321), W326 (≠ F322)
Query Sequence
>WP_028988986.1 NCBI__GCF_000423825.1:WP_028988986.1
MADYDYLIIGAGLAGASAAQGIRELDRQGSVLLIGGEPEPPYHRPPLSKGLWLGKKREED
IYVKTAPDWQAMDVALHLNDAAVELDPGGRTVTTAQGRRFGFGKLLLAMGGKPRHLPDAV
REHVFTLQTLADYRKLRALAAQGGNVLIIGGSFIGAEMACALAQQPGVRVDMLFPGPGPL
AQMLPLPLSLLLAERFREHGIHLRPEDRAVRIEATDKGSRVLTERGQVLEADWILAGVGL
EPNTALAGNAGLRVDDGVRVDAHLQSSHPGIYAAGDLANYPDPVWGDAVRIEHWDNAVAT
GRAAGRNMAGAETPFTHQSMFFSDLLDIGFEAVGRLSSRLETFVDMPADYRQGTAYYLQG
GLVRGVLLWNNWDRVEAARALIAAKQRLGPSELRGRLR
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory